Can the company reach a legally supportable EU launch with the product, evidence, people, capital and time assumed in the investment case?
Start with the thesis
What does regulatory due diligence test in an investment case?
Regulatory due diligence tests whether the exact product, proposed EU route, evidence, budget and launch timeline support the investment case. “Is the product compliant?” is usually too broad. A useful review asks what must be true for the current financing plan and launch narrative to hold. It then identifies the assumptions that can change cost, time, market access or the value of existing evidence.
Evidence review
Six connected packages—not a certificate checklist.
A strong-looking document can still cover the wrong component, claim, version or legal requirement. The review connects evidence to the exact product and investment assumptions.
The exact configuration, intended purpose, user, environment, claims and version being underwritten.
Applicable frameworks, classification logic, economic-operator roles and any binary questions that could change the route.
What existing reports and supplier documents actually cover, what is missing and who controls access.
Low–high market-entry ranges, unpriced items, rework scenarios, recurring obligations and runway impact.
Dependencies between product freeze, documentation, testing, corrective work, registration and launch.
Conditions precedent, named owners and 90-day milestones that make unresolved risk governable.
Investment committee output
See the conclusion, confidence and next evidence in one place.
The investor memo is written for action. It highlights material findings, downside drivers, financing consequences and the evidence that would raise or lower confidence. It does not bury the decision in a technical narrative.
Executive decision note
The key question, assessment, confidence and the reasons the conclusion could change.
Regulatory Entry Budget
Low–high ranges with sources, exclusions, recurring obligations and explicitly unpriced uncertainty.
Critical-path timeline
Dependencies and decision gates, rather than a single unsupported launch date.
Risk governance
Convert open risk into transaction conditions and 90-day milestones.
Not every unknown must be resolved before a deal closes. Material unknowns should, however, have an owner, evidence request, decision date and a consequence if the assumption fails.
- Before close: resolve questions that could fundamentally change the investment thesis or permitted use.
- At close: reserve budget and accountability for route-critical evidence and specialist work.
- Post close: attach measurable evidence milestones to the board plan and financing runway.
Open the fictional sample investment memo to see how those conditions can be expressed.
Important boundary
Decision support is not an investment recommendation or legal opinion.
The assessment is indicative and depends on the supplied product facts and evidence. It does not make a formal regulatory classification, certify a product, replace legal advice, or tell an investor to invest or not invest. Specialist validation may be required for higher-risk or borderline products.